A Study to Investigate the Effects of PF00610335 on the QT/QTC Interval in Healthy Volunteers

Clinical trial NCT01107054 · COMPLETED

Trial details

NCT number: NCT01107054
Sponsor: Pfizer
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Pulmonary Disease Lung Disease Moxifloxacin

Start date: 2010-06-01
Primary completion: 2010-09-01
Enrollment: 48

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.